跳转至内容
Merck
CN

860798O

Avanti

CP-LC-1067

Avanti Research - A Croda Brand

别名:

Octyl 2-methyl-14-((3-(octyloxy)-3-oxopropyl)thio)-6,9-dioxo-7-(2-((3-oxo-3-(tridecyloxy)propyl)thio)ethyl)-17-thia-2,5,8-triazaicosan-20-oate

登录 查看组织和合同定价。

选择规格

变更视图

关于此项目

经验公式(希尔记法):
C54H103N3O8S3
分子量:
1018.61
NACRES:
NA.21
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


biological source

synthetic

assay

>99% (TLC)

form

powder

manufacturer/tradename

Avanti Research - A Croda Brand

packaging

pkg of pkg of 1 x 5 mg (860798O-5MG) pkg of 1 x 25 mg (860798O-25MG)

application(s)

advanced drug delivery

lipid type

transfection
cationic lipids

shipped in

dry ice

storage temp.

−20°C

General description

CP-LC-1067 is an ionizable lipid suitable for LNP formulation research.

Application

advanced drug delivery

Features and Benefits

Compared to industry-leading lipid nanoparticle (LNP) formulations which have a primary biodistribution in the liver, LNPs formulated using the ionizable lipid CP-LC-1067 exhibit targeted lung tissue selectivity.

Other Notes

In formulations, the pKa is approximately 8.45.

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC


存储类别

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库